­µ¡¥ADPKD¤Ë¤ª¤±¤ëÉ°ø°äÅÁ»Ò1)2)
¡¡¾ïÀ÷¿§ÂÎÍ¥À­Â¿È¯À­Ç¹Ë¦¿ÕADPKD¤ÎÉ°ø°äÅÁ»ÒADPKD¤ÎÉ°ø°äÅÁ»Ò¤È¤·¤Æ¡¢´µ¼Ô²È·Ï¤ÎÏ¢º¿²òÀϤˤè¤êÂè16À÷¿§ÂÎûÏÓ¤ÎPKD1°äÅÁ»Ò¤ÈÂè4À÷¿§ÂÎĹÏÓ¤ÎPKD2°äÅÁ»Ò¤¬Æ±Äꤵ¤ì¤¿1)¡£Ìó85%¤Î´µ¼Ô¤ËPKD1°äÅÁ»Ò°Û¾ï¤¬¡¢15%¤Î´µ¼Ô¤ËPKD2°äÅÁ»Ò°Û¾ï¤¬Ç§¤á¤é¤ì¤ë¡£¤Þ¤¿¡¢PKD1°äÅÁ»Ò¤ª¤è¤ÓPKD2°äÅÁ»Ò¤Î¤¤¤º¤ì¤Ë¤âÏ¢º¿¤·¤Ê¤¤´µ¼Ô²È·Ï¤âÊó¹ð¤µ¤ì¤Æ¤ª¤êPKD3°äÅÁ»Ò¤Î¸ºß¤¬Í½ÁÛ¤µ¤ì¤ë¤¬¡¢¸½»þÅÀ¤Ç¤ÏƱÄꤵ¤ì¤Æ¤¤¤Ê¤¤¡£

­¶¡¥PKD°äÅÁ»ÒÃÁÇò¥Ý¥ê¥·¥¹¥Á¥ó¤Îµ¡Ç½
¡¡PKD1°äÅÁ»Ò¤Ï¥Ý¥ê¥·¥¹¥Á¥ó1ÃÁÇò¤ò¡¢PKD2°äÅÁ»Ò¤Ï¥Ý¥ê¥·¥¹¥Á¥ó2ÃÁÇò¤ò»ºÀ¸¤¹¤ë¡£¿Õ¡ǢºÙ´ÉºÙ˦¤Ç¤Ï¥Ý¥ê¥·¥¹¥Á¥ó1¤ª¤è¤Ó2ÃÁÇò¤Îȯ¸½¤¬³Îǧ¤µ¤ì¤Æ¤¤¤ë¡£
¡¡¥Ý¥ê¥·¥¹¥Á¥ó1¤Ï¡¢ºÙ˦¡¦ºÙ˦´Ö¤Þ¤¿¤ÏºÙ˦¡¦ºÙ˦³°¥Þ¥È¥ê¥Ã¥¯¥¹´Ö¤ÎÀÜÃåÃÁÇò¡¢¤¢¤ë¤¤¤ÏºÙ˦Ëì¾å¤Ç¤Î¼õÍÆÂΤȤ·¤ÆºÙ˦Áý¿£¤äºÙ˦Æ⥷¥°¥Ê¥ëÅÁã¤Ë´ØÍ¿¤·¡¢¥Ý¥ê¥·¥¹¥Á¥ó2¤Ï¡¢ºÙ˦Ë줢¤ë¤¤¤ÏºÙ˦Æâ¾®´ï´±Æâ¤Ç¥¤¥ª¥ó¥Á¥ã¥ó¥Í¥ë¤È¤·¤Æµ¡Ç½¤·¤Æ¤¤¤ë¤È¿äÄꤵ¤ì¤Æ¤¤¤ë3)4)¡£
¡¡¶áǯ¡¢Ç¢ºÙ´ÉºÙ˦¤Î´É¹Ð¦¤Ë¤¢¤ëprimary cilia¤ÎºÙ˦Ëì¾å¤Ç¥Ý¥ê¥·¥¹¥Á¥ó1¤È¥Ý¥ê¥·¥¹¥Á¥ó2¤¬Ê£¹çÂΤò·ÁÀ®¤·¡¢¥Ý¥ê¥·¥¹¥Á¥ó1¤¬Ç¢¤Îή¤ì¤ò´¶ÃΤ¹¤ë¥»¥ó¥µ¡¼¤È¤·¤ÆƯ¤­¡¢¥Ý¥ê¥·¥¹¥Á¥ó2¤¬¥«¥ë¥·¥¦¥à¥Á¥ã¥ó¥Í¥ë¤È¤·¤ÆºÙ˦Æâ¤Ø¤Î¥«¥ë¥·¥¦¥àήÆþ¤òÄ´Àᤷ¤Æ¤¤¤ë¤È¤¤¤¦Àâ5)¤¬Ä󾧤µ¤ì¤Æ¤¤¤ë¡£

­·¡¥PKD°äÅÁ»Ò°Û¾ï¤Èǹ˦·ÁÀ®¤Ë¤Ä¤¤¤Æ
¡¡ADPKD¤Ç¤Ï¥Ý¥ê¥·¥¹¥Á¥ó¤Î°Û¾ï¤¬Ç¹Ë¦·ÁÀ®¤Ê¤É¤ÎÉÂÂ֤˴ØÏ¢¤·¤Æ¤¤¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¤¬¡¢PKD°äÅÁ»Ò¤Î°Û¾ï¤¬Ç¹Ë¦·ÁÀ®¤Ë´ØÍ¿¤¹¤ëµ¡½ø¤Ë¤Ä¤¤¤Æ¤Ï¡¢¸½»þÅÀ¤Ç¤Ï¤ï¤«¤Ã¤Æ¤¤¤Ê¤¤¡£°ìÊýǹ˦¤Î³ÈÂç¤Ë´Ø¤·¤Æ¤Ï¡¢protein kinase A¤äEpidermal Growth Factor¤ò²ð¤¹¤ëǹ˦¤Î³ÈÂ絡½ø¤¬ÇÝÍܺÙ˦¡¦Æ°Êª¥â¥Ç¥ë¤Ç³Îǧ¤µ¤ì¡¢º£¸å¡¢ADPKD´µ¼Ô¤Ëǹ˦³ÈÂçÍÞÀ©¤Ë¤è¤ë¼£ÎŤθ¡Æ¤¤¬¿Ê¤à²ÄǽÀ­¤¬¤¢¤ë¡£
¡¡PKD2¤ËÏ¢º¿¤¹¤ë²È·Ï¤ÏPKD1¤ËÏ¢º¿¤¹¤ë²È·Ï¤ËÈæ³Ó¤·Í½¸å¤¬Îɹ¥¤Ç¤¢¤ë¤ÈÊó¹ð¤µ¤ì¤Æ¤¤¤ë¤¬¡¢Æ±¤¸°äÅÁ»Ò°Û¾ï¤ò»ý¤Ã¤Æ¤¤¤ë¤Ï¤º¤ÎƱ°ì²È·ÏÆâ¤Ç¤â¸Ä¡¹¤Î¾ÉÎã¤Ë¤è¤êͽ¸å¤Ë°ã¤¤¤¬¤¢¤ë¤³¤È¤«¤é¡¢PKD°äÅÁ»Ò°Ê³°¤Ëͽ¸å¤òµ¬Äꤹ¤ë°ø»Ò¤Î¸ºß¤¬ÁÛÄꤵ¤ì¤Æ¤¤¤ë¡£
¡Ú²¾Àâ6)¡Û
¡¡PC1(polycystin 1)¤ÈPC2(polycystin 2)¤ÏºÙ˦ÆâÉôʬ¤Ç¡¢Áê¸ß¤Ë´ØÏ¢¤ò»ý¤Ã¤Æµ¡Ç½¤·¤Æ¤¤¤ë¡£PC1¤ÈPC2¤ÏÇ¢ºÙ´ÉºÙ˦Á¡ÌÓ(cilia)¤Ë¶¦Â¸¤·¡¢Ç¢ºÙ´É±Õ¤Îή¤ì¤ò´¶ÃΤ·¤ÆºÙ˦Æâ¤ËCa2+¥¤¥ª¥ó¤òήÆþ¤µ¤»¤ëƯ¤­¤ò¤·¤Æ¤¤¤ë¡£PC2¤Ïendoplasmic reticulum(ER)¤ËË­ÉÙ¤Ëȯ¸½¤·¤Æ¤ª¤ê¡¢transient receptor potential (TRP) channel superfamily ¤Îsubfamily ¥á¥ó¥Ð¡¼¤Ç¤¢¤ë¡£¡¡PC2¤ÏCa¥¤¥ª¥ó¤Ë¤è¤Ã¤Æ³èÀ­²½¤µ¤ì¤ë¡¢high conductance ER channel¤Ç¡¢2²ÁÍÛ¥¤¥ª¥ó¤ËÂФ·¤ÆÆ©²áÀ­¤òÍ­¤¹¤ë¡£PKDºÙ˦¤Ç¤Ï¡¢¤³¤Îµ¡Ç½¤¬ÁÓ¼º¤·¤Æ¤¤¤ë°Ù¡¢ºÙ˦ÆâCaÇ»ÅÙ¤¬Äã²¼¤¹¤ë¡£
¡¡EGF receptor(EGFR)¤Ï¡¢PKDºÙ˦¤Ç²á¾êȯ¸½¤·¤Æ¤¤¤ë¤¬¡¢EGFR¤Î²¼Î®¤Ë¤¢¤ëRaf1, MEK, ERK¤Î»É·ãÅÁã·Ï¤ÏºÙ˦Áý¿£¤ò»É·ã¤¹¤ë(Àµ¾ïºÙ˦¤Ç¤Ïcyclic-AMP¤Ë¤è¤Ã¤Æ³èÀ­²½¤µ¤ì¤ëPKA¤Ï¤³¤ÎEGF°Ê²¼¤Î»É·ãÅÁã·Ï¤òÍÞÀ©¤·¤Æ¤¤¤ë)¡£PKDºÙ˦¤Ç¤Ïcyclic-AMP¤Ë¤è¤Ã¤Æ³èÀ­²½¤µ¤ì¤ëPKA¤Ï¡¢ºÙ˦ÆâCa2+¥¤¥ª¥óÇ»ÅÙ¤¬Äã²¼¤·¤Æ¤¤¤ë¤³¤È¤¬¸¶°ø¤È¤Ê¤ê¡¢EGF°Ê²¼¤Î»É·ãÅÁã·Ï¤ò»É·ã¤¹¤ë¡£¤½¤Î°Ù¡¢PKDºÙ˦¤Ç¤Ïcyclic-AMP¤¬ºÙ˦Áý¿£¤ò»É·ã¤¹¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡£cyclic-AMP¤Ë¤è¤Ã¤Æ³èÀ­²½¤µ¤ì¤ëPKA¤Ïapical¦¤Ë¤¢¤ëCFTR¡ÊCl¤ÎËì¤ò²ð¤¹¤ëžÁ÷¤òÂ¥¿Ê¤¹¤ë¡Ë¤ò»É·ã¤·¤Æ¡¢Ç¹Ë¦Æâ¤Ø¤ÎClʬÈç¤ò¹â¤á¤ë¡£
¡¡°ì¸Ä¤ÎºÙ˦¤ÎPKD°äÅÁ»Ò¤ÎæõºÙ˦ÊÑ°Û¤ËÉÕ¤±²Ã¤¨¤Æ¡¢ÂÐΩ°äÅÁ»Ò¤ÎÂκÙ˦ÊÑ°Û¡¦·ç¼º¤¬µ¯¤­¤Æ(second hit)¡¢¤½¤ÎºÙ˦¤¬¥â¥Î¥¯¥í¡¼¥Ê¥ë¤ËÁý¿£¤·¤Æǹ˦¤ò·ÁÀ®¤¹¤ëÆóÃʳ¬À⤬¼¨¤µ¤ì¤Æ¤¤¤ë¡£

1)The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 77: 881-894, 1994
2)Mochizuki T, Wu G, Hayashi T, et al.: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 272: 1339-1342,1996.
3)Gonzalez-Perrett S, Batelli M, Kim K, et al.: Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA. 98: 1182-1187, 2001.
4)Koulen P, Cai Y, Geng L, et al.: Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol. 4: 191-197, 2002.
5)Nauli SM, Alenghat FJ, Luo Y, et al.: Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 33: 129-137, 2003.
6)¸üÀ¸Ï«Æ¯¾Ê ¿ÕŽ¥ÈçÇ¢´ï·Ï¼À´µÄ´ºº¸¦µæÈÉ Â¿È¯À­Ç¹Ë¦¿Õ(2006.11.17